Same points, same date — which occupation gives you the better odds?
| Medical Oncologist253314 | Endocrinologist253315 | |
|---|---|---|
| Capacity | 525 · FY2026-27 | 525 · FY2026-27 |
| Standing | #— of 196 | #— of 196 |
| Queue position | 0 ahead | 0 ahead |
| Latest round | 2025-11-13 · 80 pts | 2026-06-04 · 80 pts |
| EOI data · pool & queue trend | 2 | 2 |
| EOI data · submission & invitation trend | — | — |
| Next round | — | — |
| Open states | 4 listed | 4 listed |
| Invited profile | — | — |
| Grants | 1 · 189 | 0 · 189 |
| Where they were granted | QLD 1 | — |
| Who was granted | India 50% | Sri Lanka 40% |
| Assessing authority | MedBA | MedBA |
Occupations in unit group 2533 share 525 places left.
Unit group 2533 · 2025-26 official: 578 ceiling · 473 remaining
Unit group 2533 · 2025-26 official: 578 ceiling · 473 remaining
Standing is tied.
Both have the same number of people ahead of you.
The latest cutoff is the same for both.
Up from 65 vs previous round
Other subclasses491 · 70 pts · 22 Aug 2022
See full round history →Down from 95 vs previous round
Other subclasses491 · 65 pts · 8 Dec 2022
See full round history →The EOI pool is the same size for both.
Queue at your points · 6 months
0 at 85+ pts
▬ 0 vs last month
Queue at your points · 6 months
0 at 85+ pts
▬ 0 vs last month
Both drew the same number of invitations last month.
No next-round estimate available.
Both are open in the same number of states.
Subclass 189 is the federal, points-tested stream — states do not nominate for it. Switch to 190 or 491 to compare open states.
At least one occupation has no state-nomination community data, so this row isn't compared.
Subclass 189 has no state-nomination community data. Compare on 190 or 491 to see an invited profile.
In 2024-25, Medical Oncologist had 1 subclass 189 main-applicant grants and Endocrinologist had 0. Grants trail invitations by months: read this as context, not as your chances.
1
subclass 189 main applicants · 2024-25
0
subclass 189 main applicants · 2024-25
Top state for subclass 189 grants in 2024-25: Medical Oncologist QLD (1); Endocrinologist none.
Most common nationality, 2022-23 to 2024-25: Medical Oncologist India (50%); Endocrinologist Sri Lanka (40%). Applied from within Australia in 2024-25: Medical Oncologist 100%; Endocrinologist 100%.
Nationality, 2022-23 to 2024-25 combined
Nationality, 2022-23 to 2024-25 combined
MedBA may assess both occupations. Verify on the assessing authority's site before you apply.
MedBA